Dark

Check out our Dark Pool Levels

APEN
Apollo Endosurgery, Inc.
stock NASDAQ

Inactive

Apr 3, 2023

10.00USD+0.806%(+0.08)1,658,846

Pre-market

0.00USD-100.000%(-9.92)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 10, 2022

04:08PM EST Apollo Endosurgery Sees Q4 Sales $16.1M-$16.3M vs $16.5M Estimate; FY21 Total Sales $62.9M-$63.1M vs $63.3M Est. Benzinga

Dec 15, 2021

10:05AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 Benzinga

06:16AM EST Cowen & Co. Initiates Coverage On Apollo Endosurgery with Outperform Rating, Announces Price Target of $13 Benzinga

Dec 9, 2021

09:50PM EST Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021 Benzinga

09:45PM EST Stifel Initiates Coverage On Apollo Endosurgery with Buy Rating, Announces Price Target of $12 Benzinga

Nov 2, 2021

10:26AM EDT Recap: Apollo Endosurgery Q3 Earnings Benzinga

10:18AM EDT Apollo Endosurgery Sees FY21 Sales $63M-$64M vs $62.72M Est. Benzinga

10:18AM EDT Apollo Endosurgery Q3 EPS $(0.23) Beats $(0.28) Estimate, Sales $16.40M Beat $15.47M Estimate Benzinga

Nov 1, 2021

04:01AM EDT Earnings Scheduled For November 1, 2021 Benzinga

Oct 29, 2021

10:42AM EDT Apollo Endosurgery's Earnings Outlook Benzinga

Oct 22, 2021

04:06PM EDT Apollo Endosurgery Announces MERIT-Trial Met Primary Endpoints For Safety And Efficacy Benzinga

Oct 20, 2021

05:18AM EDT Apollo Endosurgery Director Kent McGaughy Reported Purchase of 683,871 Shares @ Avg Price of $7.75/Share in Form 4 Filing on Tuesday Benzinga

Oct 13, 2021

06:43AM EDT The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 06.15 A.M. EDT). RTTNews

Oct 12, 2021

04:02PM EDT Apollo Endosurgery Announces Commencement Of Public Offering Of Common Stock; Size Not Disclosed Benzinga

Oct 7, 2021

04:09PM EDT Apollo Endosurgery Sees Q3 Operating Loss $5.2M-$4.1M, Adj. EBITDA Loss $3M-$2.1M Benzinga

04:08PM EDT Apollo Endosurgery Sees Q3 Sales $16M-$16.4M vs $14.4M Estimate Benzinga

Sep 9, 2021

11:05AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 Benzinga

08:09AM EDT Stephens & Co. Initiates Coverage On Apollo Endosurgery with Overweight Rating, Announces Price Target of $15 Benzinga

Aug 20, 2021

01:44PM EDT Return on Capital Employed Overview: Apollo Endosurgery Benzinga

Aug 3, 2021

04:33PM EDT Apollo Endosurgery Raises FY21 Sales Guidance From $55M-$57M To $61M-$63M Vs. $55.58M Est. Benzinga

04:32PM EDT Apollo Endosurgery Q2 EPS $(0.11) Beats $(0.20) Estimate, Sales $16.61M Beat $13.67M Estimate Benzinga

03:52AM EDT Earnings Scheduled For August 3, 2021 Benzinga

Jul 16, 2021

07:05AM EDT Apollo Endosurgery Names Jeffrey Black CFO Benzinga

Jun 14, 2021

10:44AM EDT UPDATE: Piper Sandler On Apollo Overweight Reiteration, Believes 'the data from MERIT will both help change payor behavior and FDA labeling over time, which we believe will drive strong procedure adoption (and APEN revenue growth) in the coming years' Benzinga

10:01AM EDT Piper Sandler Maintains Overweight on Apollo Endosurgery, Raises Price Target to $11 Benzinga

09:51AM EDT Apollo Endosurgery Shares Up 3%; Piper Sandler Raises Price Target From $9 To $11, Reiterates Overweight Rating Benzinga

07:33AM EDT Apollo Endosurgery Announces MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints Benzinga

May 24, 2021

07:05AM EDT Apollo Endosurgery Highlights Presentation Featuring OverStitch Endoscopic Suturing System Highlighted During Digestive Disease Week 2021 Benzinga

May 17, 2021

12:10PM EDT Lake Street Initiates Coverage On Apollo Endosurgery with Buy Rating, Announces Price Target of $12 Benzinga

May 4, 2021

04:32PM EDT Apollo Endosurgery Q1 EPS $(0.17) Beats $(0.22) Estimate, Sales $13.90M Beat $11.71M Estimate Benzinga

May 3, 2021

08:03AM EDT Urges Shareholders to Vote the WHITE Proxy Card FOR ALL Four of MIMEDXs Director Nominees Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner GlobeNewswire Inc

Apr 21, 2021

04:30PM EDT Apollo Endosurgery Announces Publication Of Pre-Clinical Results For X-Tack Endoscopic HeliX Tacking System Benzinga

Mar 8, 2021

08:41AM EST Apollo Endosurgery Reports Assignment Of Category I Current Procedrual Terminology Codes For Deployment Of Gastric Bariatric Device Under Endoscopic Guidance Benzinga

Mar 2, 2021

08:21AM EST Apollo Endosurgery Granted US Patent Titled 'Method of implanting an intragastric balloon' Benzinga

Mar 1, 2021

06:32AM EST Apollo Endosurgery Received FDA Breakthrough Device Designation for the Orbera Intragastric Balloon for Treatment of Patients with NASH Benzinga

Feb 25, 2021

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

10:23AM EST Apollo Endosurgery's Earnings: A Preview Benzinga

Feb 9, 2021

05:48AM EST Apollo Endosurgery 1-%+ Owner Neil Gagnon Reported Purchase of 53,543 Shares @Acg Price of $.85/Share in Form 4 Filing on Monday Benzinga

Feb 8, 2021

04:44PM EST Apollo Endosurgery 8-K Shows Co. Names Charles McKhann Pres, CEO Benzinga

Dec 16, 2020

06:17AM EST A Peek Into The Markets: US Stock Futures Rise Ahead Of Fed Decision Benzinga

Dec 15, 2020

04:54PM EST Apollo Endosurgery, Inc. (APEN) - Shares of the medical devices maker jumped 15% in after hours trading Tuesday. Apollo Endosurgery said it received FDA clearance for the X-Tack Endoscopic HeliX Tacking System. X-Tack is a new, through-the-scope, suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. RTTNews

04:01PM EST Apollo Endosurgery Receives FDA Clearance for the X-Tack(TM) Endoscopic HeliX Tacking System Benzinga

Nov 30, 2020

02:30PM EST Mid-Afternoon Market Update: Dow Tumbles 350 Points; SuperCom Shares Spike Higher Benzinga

12:21PM EST Mid-Day Market Update: Crude Oil Down Over 1%; Nikola Shares Plunge Benzinga

08:26AM EST 10 Biggest Price Target Changes For Monday Benzinga

05:58AM EST Piper Sandler Upgrades Apollo Endosurgery to Overweight, Raises Price Target to $5 Benzinga

Nov 5, 2020

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Oct 1, 2020

04:05PM EDT Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that medical device industry veteran Rick Anderson has joined its board of directors. GlobeNewswire Inc

Sep 1, 2020

07:01PM EDT SHAREHOLDER ALERT: WeissLaw LLP Investigates Apollo Endosurgery, Inc. PR Newswire

Aug 4, 2020

04:31PM EDT Apollo Endosurgery Q2 EPS $(0.30) Beats $(0.33) Estimate, Sales $5.60M Beat $5.19M Estimate Benzinga

05:19AM EDT Earnings Scheduled For August 4, 2020 Benzinga

Share